Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (731-740 of 934) with videos related to

Pageof 94
Sort By:
Journal of the American Heart Association|April 16, 2017
Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major BleedingDaniel Lindholm, Emil Hagström, Stefan K James, et al.
European Heart Journal|March 4, 2014
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registryDharam J Kumbhani, Ph Gabriel Steg, Christopher P Cannon, et al.
Critical Pathways in Cardiology|March 15, 2008
Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 RegistryChristopher P Cannon, Maria Cecilia Bahit, J Mark Haugland, et al.
American Heart Journal|May 21, 2019
Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAxel Åkerblom, Daniel M Wojdyla, Lars Wallentin, et al.
Journal of Clinical Lipidology|September 15, 2020
Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in the ODYSSEY CHOICE I trialEli M Roth, John J P Kastelein, Christopher P Cannon, et al.
JAMA Cardiology|January 21, 2026
Patient Engagement With Home Blood Pressure MonitoringOzan Unlu, David Zelle, Christopher P Cannon, et al.
Journal of the American College of Cardiology|June 7, 2005
Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration ratesAjay J Kirtane, David M Leder, Sushrut S Waikar, et al.
The American Journal of Cardiology|September 8, 2001
Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapyJ A de Lemos, D A Morrow, C M Gibson, et al.
Circulation. Cardiovascular Quality and Outcomes|January 12, 2012
Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease programFeng Qian, Frederick S Ling, Prakash Deedwania, et al.
Clinical Cardiology|June 8, 2012
A point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive CardiologyParag H Joshi, Sameer Chaudhari, Michael J Blaha, et al.
Pageof 94

Showing results (731-740 of 934) with videos related to

Sort By:
Pageof 94
Journal of the American Heart Association|April 16, 2017
Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major BleedingDaniel Lindholm, Emil Hagström, Stefan K James, et al.
European Heart Journal|March 4, 2014
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registryDharam J Kumbhani, Ph Gabriel Steg, Christopher P Cannon, et al.
Critical Pathways in Cardiology|March 15, 2008
Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 RegistryChristopher P Cannon, Maria Cecilia Bahit, J Mark Haugland, et al.
American Heart Journal|May 21, 2019
Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAxel Åkerblom, Daniel M Wojdyla, Lars Wallentin, et al.
Journal of Clinical Lipidology|September 15, 2020
Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in the ODYSSEY CHOICE I trialEli M Roth, John J P Kastelein, Christopher P Cannon, et al.
JAMA Cardiology|January 21, 2026
Patient Engagement With Home Blood Pressure MonitoringOzan Unlu, David Zelle, Christopher P Cannon, et al.
Journal of the American College of Cardiology|June 7, 2005
Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration ratesAjay J Kirtane, David M Leder, Sushrut S Waikar, et al.
The American Journal of Cardiology|September 8, 2001
Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapyJ A de Lemos, D A Morrow, C M Gibson, et al.
Circulation. Cardiovascular Quality and Outcomes|January 12, 2012
Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease programFeng Qian, Frederick S Ling, Prakash Deedwania, et al.
Clinical Cardiology|June 8, 2012
A point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive CardiologyParag H Joshi, Sameer Chaudhari, Michael J Blaha, et al.
Pageof 94